241 related articles for article (PubMed ID: 9151222)
1. Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy.
Sjöberg S; Carlsson J; Ghaneolhosseini H; Gedda L; Hartman T; Malmquist J; Naeslund C; Olsson P; Tjarks W
J Neurooncol; 1997 May; 33(1-2):41-52. PubMed ID: 9151222
[TBL] [Abstract][Full Text] [Related]
2. Boronated DNA-binding compounds as potential agents for boron neutron capture therapy.
Crossley EL; Ziolkowski EJ; Coderre JA; Rendina LM
Mini Rev Med Chem; 2007 Mar; 7(3):303-13. PubMed ID: 17346220
[TBL] [Abstract][Full Text] [Related]
3. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of primary and metastatic brain tumors.
Barth RF; Soloway AH
Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
[TBL] [Abstract][Full Text] [Related]
5. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Kreimann E; Farías S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA
Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734
[TBL] [Abstract][Full Text] [Related]
6. Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy.
Luderer MJ; Muz B; Alhallak K; Sun J; Wasden K; Guenthner N; de la Puente P; Federico C; Azab AK
Pharm Res; 2019 Aug; 36(10):144. PubMed ID: 31392417
[TBL] [Abstract][Full Text] [Related]
7. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH
J Neurooncol; 1997 May; 33(1-2):59-70. PubMed ID: 9151224
[TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of boronated unnatural amino acids as new boron carriers.
Kabalka GW; Yao ML; Marepally SR; Chandra S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S374-9. PubMed ID: 19398346
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy.
Wyzlic IM; Tjarks W; Soloway AH; Anisuzzaman AK; Rong FG; Barth RF
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1203-13. PubMed ID: 8175406
[TBL] [Abstract][Full Text] [Related]
10. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
[TBL] [Abstract][Full Text] [Related]
12. Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter.
Miyabe J; Ohgaki R; Saito K; Wei L; Quan L; Jin C; Liu X; Okuda S; Nagamori S; Ohki H; Yoshino K; Inohara H; Kanai Y
J Pharmacol Sci; 2019 Mar; 139(3):215-222. PubMed ID: 30833090
[TBL] [Abstract][Full Text] [Related]
13. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
Morris GM; Micca PL; Coderre JA
Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
15. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.
Yang W; Barth RF; Bartus RT; Rotaru JH; Moeschberger ML; Ferketich AK; Nawrocky MM; Coderre JA; Goodman JH
Neurosurgery; 2000 Jul; 47(1):189-97; discussion 197-8. PubMed ID: 10917362
[TBL] [Abstract][Full Text] [Related]
16. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a novel liposome containing BPA-peptide conjugate for BNCT.
Shirakawa M; Yamamto T; Nakai K; Aburai K; Kawatobi S; Tsurubuchi T; Yamamoto Y; Yokoyama Y; Okuno H; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S88-90. PubMed ID: 19446462
[TBL] [Abstract][Full Text] [Related]
18. Boronated compounds for imaging guided BNCT applications.
Geninatti-Crich S; Deagostino A; Toppino A; Alberti D; Venturello P; Aime S
Anticancer Agents Med Chem; 2012 Jun; 12(5):543-53. PubMed ID: 22263798
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of boron in malignant and normal cells incubated in vitro with boronophenylalanine, mercaptoborane or boric acid.
Capala J; Makar MS; Coderre JA
Radiat Res; 1996 Nov; 146(5):554-60. PubMed ID: 8896582
[TBL] [Abstract][Full Text] [Related]
20. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]